320
Participants
Start Date
September 18, 2018
Primary Completion Date
April 12, 2019
Study Completion Date
April 12, 2019
Amphetamine Sulfate
active experimental AR19
Placebo
Matching placebo
118: Bioscience Research, LLC, Mount Kisco
126: Coastal Carolina Research, Mt. Pleasant
104: Northwest Behavioral Research Center, Marietta
129: Sarkis Clinical Trials, Gainesville
120: Meridien Research, Maitland
130: Medical Research Group of Central Florida, Orange City
123: APG Research, LLC, Orlando
115: Clinical Neuroscience Solutions (CNS), Inc., Orlando
105: Meridien Research, Lakeland
103: Gulfcoast Clinical Research Center, Fort Myers
108: Meridien Research, Bradenton
102: Clinical Neuroscience Solutions (CNS), Inc., Memphis
132: Research Strategies of Memphis, Memphis
119: Neurobehavioral Clinical Research, Inc., Canton
134: Rochester Center for Behavioral Medicine, Rochester Hills
128: Clinical Neurophysiology Services, Sterling
113: Capstone Clinical Research, Libertyville
110: FutureSearch Trials of Dallas, Dallas
117: Houston Clinical Trials, LLC, Houston
125: Biobehavioral Research of Austin, Austin
109: Ericksen Research and Development, Clinton
131: Advanced Clinical Research, Inc., Meridian
107: Center for Psychiatry and Behavioral Medicine, Las Vegas
114: Pharmacology Research Institute, Encino
124: Pharmacology Research Institute, Newport Beach
133: Collaborative Neuroscience Network, Garden Grove
106: Summit Research Network, Portland
121: CT Clinical Research Associates, Cromwell
116: Alliance - Hassman Research Institute, Berlin
127: Center for Emotional Fitness, Cherry Hill
101: Princeton Medical Institute, Princeton
Lead Sponsor
Arbor Pharmaceuticals, Inc.
INDUSTRY